• No results found

CHAPTER 4: DISCUSSION 4.1. Summary of main results

4.7. Implications for further research

This systematic review advocates the need for further high-quality, more adequately powered, large-scale RCTs conducted in different countries with a more diverse population and free-living conditions when possible. A clear definition of what ADF actually constitutes needs to be

established. It should also be mentioned that both the feelings of appetite and body weight measurements are different in feed and fast days. Hence, future trials of ADF should average measurements taken from consecutive feed and fast days throughout the day to attain more accurate assessments. Examining the adherence to ADF in relation to cognitive, environmental, psychological, and/or physiological factors, identifying barriers and facilitators to this approach, and defining which populations may gain the most benefit and why will help to better

comprehend the effects of this intervention and assess the feasibility. Evaluating the impact of

52

ADF on appetite hormones such as ghrelin, PYY, or GLP-1, and ketone bodies during weight loss and weight maintenance is needed. As clinical guidelines require interventions that are deemed both clinically and cost effective, economic evaluations of this approach are also required. Long-term trials are needed to fully investigate the effects of ADF on appetite, weight loss, weight management, diet sustainability, and safety. As the growing interest accumulates over IER practices, it is important that future studies build on the findings of this review.

4.8. Conclusion

This systematic review summarizes and presents the effects of ADF on subjective feelings of appetite and weight loss. The findings suggest that the intervention has small or no effect on feelings of hunger, fullness, satisfaction, and desire to eat and has a small effect on body weight.

The quality of evidence is too low to draw robust conclusions and it is hard to justify the generalization of the results. While this systematic review gives promises, more rigorous, large-scale, long-term studies are needed to support the evidence in this review.

53

REFERENCES

1. Ganesan K, Habboush Y, Sultan S. Intermittent Fasting: The Choice for a Healthier Lifestyle. Cureus. 2018.

2. Kim J. Optimal Diet Strategies for weight loss and weight loss Maintenance. Journal of Obesity & Metabolic Syndrome. 2021;30(1):20-31.

3. Obesity and overweight [Internet]. World Health Organization. World Health Organization; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

4. Ritchie H, Roser M. Obesity [Internet]. Our World in Data. 2017. Available from:

https://ourworldindata.org/obesity

5. WHO Consultation on Obesity ( 1999: Geneva, Switzerland) & World Health

Organization. Obesity : preventing and managing the global epidemic : report of a WHO consultation, 2000. Available from: https://apps.who.int/iris/handle/10665/

6. Randle M. Appetite control and dietary adherence during intermittent energy restriction in naturalistic settings using Ecological Momentary Assessment [dissertation]. 2020.

7. The heavy burden of obesity: the economics of prevention. Paris: OECD Publishing;

2019.

8. Galani C, Schneider H. Prevention and treatment of obesity with lifestyle interventions:

review and meta-analysis. International Journal of Public Health. 2007;52(6):348–59.

9. Obesity [Internet]. World Health Organization. World Health Organization; Available from: https://www.who.int/health-topics/obesity#tab=tab_1

10. Semlitsch T, Stigler FL, Jeitler K, Horvath K, Siebenhofer A. Management of overweight and obesity in primary care—A systematic overview of international evidence‐based guidelines. Obesity Reviews. 2019;20(9):1218–30.

11. Zinöcker S, Reinar LM, Eggen FR, Refsdal TL, Kornør HK. Treatment options for morbid obesity: rapid review for a patient decision aid. Report 2020. Oslo: Norwegian Institute of Public Health; 2020.

12. Hansen TT, Mead BR, García-Gavilán JF, Korndal SK, Harrold JA, Camacho-Barcía L, et al. Is reduction in appetite beneficial for body weight management in the context of

54

overweight and obesity? Yes, according to the SATIN (Satiety Innovation) study. Journal of Nutritional Science. 2019;8.

13. Haslam DW, James WP. Obesity. The Lancet. 2005;366(9492):1197–209.

14. Holte HH, Denison E, Dahm KT, Hestevik CH, Hval G. Elementer i livsstilstiltak for vektreduksjon blant voksne personer med overvekt eller fedme: en kartleggingsoversikt.

Rapport 2021. Oslo: Folkehelseinstituttet; 2021.

15. Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, et al. Comparison of weight loss Among Named Diet Programs in Overweight and Obese Adults. JAMA.

2014;312(9):923.

16. Managing overweight and obesity in adults: systematic evidence review from the obesity expert panel, 2013. U.S. Department of Health and Human Services; 2013.

17. Cai H, Qin Y-L, Shi Z-Y, Chen J-H, Zeng M-J, Zhou W, et al. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterology. 2019;19(1).

18. Davis CS, Clarke RE, Coulter SN, Rounsefell KN, Walker RE, Rauch CE, et al.

Intermittent energy restriction and weight loss: a systematic review. European Journal of Clinical Nutrition. 2016;70(3):292–9.

19. Cho Y, Hong N, Kim K-won, Cho S, Lee M, Lee Y-hee, et al. The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2019Oct;8(10):1645.

20. Beaulieu K, Casanova N, Oustric P, Turicchi J, Gibbons C, Hopkins M, et al. Matched weight loss Through Intermittent or Continuous Energy Restriction Does Not Lead To Compensatory Increases in Appetite and Eating Behavior in a Randomized Controlled Trial in Women with Overweight and Obesity. The Journal of Nutrition.

2019;150(3):623–33.

21. Diet Review: Intermittent Fasting for weight loss [Internet]. The Nutrition Source. 2019.

Available from: https://www.hsph.harvard.edu/nutritionsource/healthy-weight/diet-reviews/intermittent-fasting/

22. Patterson RE, Laughlin GA, LaCroix AZ, Hartman SJ, Natarajan L, Senger CM, et al.

Intermittent Fasting and Human Metabolic Health. Journal of the Academy of Nutrition and Dietetics. 2015;115(8):1203–12.

55

23. Persynaki A, Karras S, Pichard C. Unraveling the metabolic health benefits of fasting related to religious beliefs: A narrative review. Nutrition. 2017;35:14–20.

24. Howard AN. Dietary Treatment of Obesity. Obesity: Its Pathogenesis And Management.

1975:123–53.

25. Duncan GG, Cristofori FC, Yue JK, Murthy MSJ. The Control of Obesity by Intermittent Fasts. Medical Clinics of North America. 1964;48(5):1359–72.

26. Vitale R, Kim Y. The Effects of Intermittent Fasting on Glycemic Control and Body Composition in Adults with Obesity and Type 2 Diabetes: A Systematic Review.

Metabolic Syndrome and Related Disorders. 2020;18(10):450–61.

27. Harris L, Hamilton S, Azevedo LB, Olajide J, De Brún C, Waller G, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults. JBI Database of Systematic Reviews and Implementation Reports. 2018;16(2):507–47.

28. de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease.

New England Journal of Medicine. 2019;381(26):2541–51.

29. St-Onge M-P, Ard J, Baskin ML, Chiuve SE, Johnson HM, Kris-Etherton P, et al. Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation. 2017;135(9).

30. Mirmiran P, Bahadoran Z, Gaeini Z, Moslehi N, Azizi F. Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: An updated meta-analysis. Nutrition,

Metabolism and Cardiovascular Diseases. 2019;29(9):906–15.

31. Rajpal A, Ismail‐Beigi F. Intermittent fasting and ‗metabolic switch‘: Effects on

metabolic syndrome, prediabetes and type 2 diabetes. Diabetes, Obesity and Metabolism.

2020;22(9):1496–510.

32. Schwingshackl L, Zähringer J, Nitschke K, Torbahn G, Lohner S, Kühn T, et al. Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: systematic review and meta-analyses.

Critical Reviews in Food Science and Nutrition. 2020;61(8):1293–304.

33. Hoddy KK, Gibbons C, Kroeger CM, Trepanowski JF, Barnosky A, Bhutani S, et al.

Changes in hunger and fullness in relation to gut peptides before and after 8 weeks of alternate day fasting. Clinical Nutrition. 2016;35(6):1380–5.

56

34. Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, et al.

Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutrition Journal. 2013;12(1).

35. Hart K. Chapter 4.6 Fad diets and fasting for weight loss in obesity. In: Advanced nutrition and dietetics in obesity. Hoboken, NJ: Wiley; 2018. p. 177–82.

36. Patterson RE, Sears DD. Metabolic Effects of Intermittent Fasting. Annual Review of Nutrition. 2017;37(1):371–93.

37. Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Research Reviews. 2017;39:46–58.

38. Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, Bhutani S, Hoddy KK, et al.

Effect of Alternate-Day Fasting on weight loss, Weight Maintenance, and

Cardioprotection Among Metabolically Healthy Obese Adults. JAMA Internal Medicine.

2017;177(7):930–8.

39. Jahrami HA, Alsibai J, Clark CC, Faris MA-I. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above. European Journal of Nutrition.

2020Mar;59(6):2291–316.

40. Tinsley GM, La Bounty PM. Effects of intermittent fasting on body composition and clinical health markers in humans. Nutrition Reviews. 2015;73(10):661–74.

41. Gibbons C, Hopkins M, Beaulieu K, Oustric P, Blundell JE. Issues in Measuring and Interpreting Human Appetite (Satiety/Satiation) and Its Contribution to Obesity. Current Obesity Reports. 2019;8(2):77–87.

42. Hopkins M, Blundell J, Halford J, King N, Finlayson G. The Regulation of Food Intake in Humans [Internet]. U.S. National Library of Medicine; 2016. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK278931/

43. Beaulieu K, Blundell J. Correction to: The Psychobiology of Hunger – A Scientific Perspective. Topoi. 2020.

44. Hernández Ruiz de Eguilaz M, Martínez de Morentin Aldabe B, Almiron-Roig E, Pérez-Diez S, San Cristóbal Blanco R, Navas-Carretero S, et al. Multisensory influence on eating behavior: Hedonic consumption. Endocrinología, Diabetes y Nutrición (English ed). 2018;65(2):114–25.

57

45. Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. International Journal of Obesity. 2015;39(8):1188–96.

46. Sayer R, Peters J, Pan Z, Wyatt H, Hill J. Hunger, Food Cravings, and Diet Satisfaction are Related to Changes in Body Weight During a 6-Month Behavioral weight loss Intervention: The Beef WISE Study. Nutrients. 2018;10(6):700.

47. Gibson AA, Sainsbury A. Strategies to Improve Adherence to Dietary weight loss

Interventions in Research and Real-World Settings. Behavioral Sciences. 2017Jul;7(4):44.

48. Nymo S, Coutinho SR, Eknes PH, Vestbostad I, Rehfeld JF, Truby H, et al. Investigation of the long-term sustainability of changes in appetite after weight loss. International Journal of Obesity. 2018Jun;42(8):1489–99.

49. Gibson AA, Seimon RV, Lee CM, Ayre J, Franklin J, Markovic TP, et al. Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obesity Reviews.

2014;16(1):64–76.

50. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-Term Persistence of Hormonal Adaptations to weight loss. New England Journal of Medicine. 2011;365(17):1597–604.

51. Gilbert J-A, Drapeau V, Astrup A, Tremblay A. Relationship between diet-induced changes in body fat and appetite sensations in women. Appetite. 2009;52(3):809–12.

52. Egecioglu E, Skibicka KP, Hansson C, Alvarez-Crespo M, Friberg PA, Jerlhag E, et al.

Hedonic and incentive signals for body weight control. Reviews in Endocrine and Metabolic Disorders. 2011;12(3):141–51.

53. Seimon RV, Roekenes JA, Zibellini J, Zhu B, Gibson AA, Hills AP, et al. Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Molecular and Cellular Endocrinology. 2015;418:153–72.

54. Klempel MC, Bhutani S, Fitzgibbon M, Freels S, Varady KA. Dietary and physical activity adaptations to alternate day modified fasting: implications for optimal weight loss. Nutrition Journal. 2010;9(1).

55. Horne BD, Muhlestein JB, Anderson JL. Health effects of intermittent fasting: hormesis or harm? A systematic review. The American Journal of Clinical Nutrition.

2015;102(2):464–70.

58

56. Cochrane Handbook for Systematic Reviews of Interventions [Internet]. Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training. Available from:

https://training.cochrane.org/handbook/archive/v6 57. PRISMA. Available from: http://prisma-statement.org/

58. Yeomans MR. Measuring Appetite and Food Intake. Methods in Consumer Research, Volume 2. 2018;119–49.

59. Rayyan Systems I. What if systematic review took half the time? [Internet]. Rayyan.

Available from: https://www.rayyan.ai/

60. Data Extraction and Assessment Form - template - Cochrane [Internet]. Available from:

https://epoc.cochrane.org/sites/epoc.cochrane.org/files/public/uploads/Resources-for-authors2017/good_practice_data_extraction_form.doc

61. J1 P. Cochrane Colloquium Abstracts [Internet]. Risk of Bias Assessment tool for Non-randomized Studies (RoBANS): Development and validation of a new instrument | Colloquium Abstracts. Available from: https://abstracts.cochrane.org/2011-madrid/risk-bias-assessment-tool-non-randomized-studies-robans-development-and-validation-new 62. Uthman O, Jordan J. Arthritis Research UK Primary Care Centre Systematic Review

Protocol & Support Template. University of York; 2011. Available from:

http://www.crd.york.ac.uk/PROSPEROFILES/3611_STRATEGY_20130031.pdf 63. Welcome to the GRADE working group [Internet]. GRADE home. Available from:

https://www.gradeworkinggroup.org/

64. What is GRADE? [Internet]. BMJ Best Practice. Available from:

https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/

65. Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evidence Based Medicine.

2017;22(3):85–7.

66. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. ESRC Methods Programme;

2006.

67. Bhutani S, Klempel MC, Kroeger CM, Aggour E, Calvo Y, Trepanowski JF, et al. Effect of exercising while fasting on eating behaviors and food intake. Journal of the

International Society of Sports Nutrition. 2013;10(1):50.

59

68. Kalam F, Gabel K, Cienfuegos S, Wiseman E, Ezpeleta M, Pavlou V, et al. Changes in subjective measures of appetite during 6 months of alternate day fasting with a low carbohydrate diet. Clinical Nutrition ESPEN. 2021;41:417–22.

69. Klempel MC, Kroeger CM, Norkeviciute E, Goslawski M, Phillips SA, Varady KA.

Benefit of a low-fat over high-fat diet on vascular health during alternate day fasting.

Nutrition & Diabetes. 2013;3(5).

70. Johnson JB, Summer W, Cutler RG, Martin B, Hyun D-H, Dixit VD, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radical Biology and Medicine. 2007;42(5):665–74.

71. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.

72. Jørgensen J. Timeline over which compensatory mechanisms are activated during weight loss with a very-low-calorie diet [thesis]. [Trondheim]: Norwegian University of Science and Technology; 2014.

73. Casanova N, Beaulieu K, Finlayson G, Hopkins M. Metabolic adaptations during negative energy balance and their potential impact on appetite and food intake. Proceedings of the Nutrition Society. 2019;78(3):279–89.

74. Teng NI, Shahar S, Manaf ZA, Das SK, Taha CS, Ngah WZ. Efficacy of fasting calorie restriction on quality of life among aging men. Physiology & Behavior.

2011;104(5):1059–64.

75. Welton S, Minty R, O‘Driscoll T, Willms H, Poirier D, Madden S, et al. Intermittent fasting and weight loss Systematic review. Canadian Family Physician. 2020Feb;66:117–

25.

76. Kalam F, Gabel K, Cienfuegos S, Wiseman E, Ezpeleta M, Steward M, et al. Alternate day fasting combined with a low‐carbohydrate diet for weight loss, weight maintenance, and metabolic disease risk reduction. Obesity Science & Practice. 2019;5(6):531–9.

77. Cioffi I, Evangelista A, Ponzo V, Ciccone G, Soldati L, Santarpia L, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a

60

systematic review and meta-analysis of randomized controlled trials. Journal of Translational Medicine. 2018;16(1).

78. Francis L, Young J, Lara J. The impact of intermittent fasting on body composition and cardiovascular biomarkers: a systematic review and meta-analysis. Proceedings of the Nutrition Society. 2017;76(OCE2).

79. Park J, Seo Y-G, Paek Y-J, Song HJ, Park KH, Noh H-M. Effect of alternate-day fasting on obesity and cardiometabolic risk: A systematic review and meta-analysis. Metabolism.

2020;111:154336.

80. Elsworth R, Monge A, Perry R, Brunstrom J. Effect of intermittent fasting on appetite: a systematic review [Internet]. PROSPERO CRD42021245146; 2021. Available from:

https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021245146 81. Parker BA, Sturm K, MacIntosh CG, Feinle C, Horowitz M, Chapman IM. Relation

between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. European Journal of Clinical Nutrition.

2004;58(2):212–8.

82. Douglas SM, Leidy HJ. Novel Methodological Considerations Regarding the Use of Visual Analog Scale (VAS) Appetite Questionnaires in Tightly Controlled Feeding Trials.

Current Developments in Nutrition. 2019;3(6).

83. Nestoriuc Y, Martin A, Rief W. Combining effect sizes from controlled and uncontrolled study designs: benefit, bias, and control strategies [Internet]. Cochrane Colloquium Abstracts. The Cochrane Collaboration; Available from:

https://abstracts.cochrane.org/2008-freiburg/combining-effect-sizes-controlled-and-uncontrolled-study-designs-benefit-bias-and

84. Goodacre S. Uncontrolled before-after studies: discouraged by Cochrane and theEMJ.

Emergency Medicine Journal. 2015Mar;32(7):507–8.

85. Adult Weight Management AWM: EXECUTIVE SUMMARY OF

RECOMMENDATIONS (2014) [Internet]. EAL. Academy of Nutrition and Dietetics;

2021. Available from: https://www.andeal.org/topic.cfm?menu=2798&cat=4690

61

62 APPENDICES Appendix 1. PRISMA 2020 Checklist

Section and

Title 1 Identify the report as a systematic review. Cover

ABSTRACT

Abstract 2 See the PRISMA 2020 for Abstracts checklist. v

INTRODUCTION

Rationale 3 Describe the rationale for the review in the context of existing knowledge. 13

Objectives 4 Provide an explicit statement of the objective(s) or question(s) the review addresses. 15 METHODS

Eligibility criteria 5 Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses. 16 Information

sources

6 Specify all databases, registers, websites, organisations, reference lists and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted.

18, 69 Search strategy 7 Present the full search strategies for all databases, registers and websites, including any filters and limits used. 69 Selection

process

8 Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, details of automation tools used in the process.

18

Data collection process

9 Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process.

19

Data items 10a List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g. for all measures, time points, analyses), and if not, the methods used to decide which results to collect.

73

10b List and define all other variables for which data were sought (e.g. participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information.

73 Study risk of

bias assessment

11 Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used in the process.

19

Effect measures 12 Specify for each outcome the effect measure(s) (e.g. risk ratio, mean difference) used in the synthesis or presentation of results.

20

63

13a Describe the processes used to decide which studies were eligible for each synthesis (e.g. tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)).

20, 21 13b Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing summary

statistics, or data conversions.

19 13c Describe any methods used to tabulate or visually display results of individual studies and syntheses. 20, 21 13d Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was

performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and software package(s) used.

20

13e Describe any methods used to explore possible causes of heterogeneity among study results (e.g. subgroup analysis, meta-regression).

20, 21 13f Describe any sensitivity analyses conducted to assess robustness of the synthesized results. 45 Reporting bias

assessment

14 Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases). 21 Certainty

assessment

15 Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome. 21, 22 RESULTS

Study selection 16a Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram.

24 16b Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were

excluded.

129 Study

characteristics

17 Cite each included study and present its characteristics. 25, 26

Risk of bias in studies

18 Present assessments of risk of bias for each included study. 30-35

Results of individual studies

19 For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g. confidence/credible interval), ideally using structured tables or plots.

35-44

Results of syntheses

20a For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies. 35-44 20b Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary

20a For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies. 35-44 20b Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary